Applications

1144 – Pathology Tests for Latent Mycobacterial Infection

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type New application
  • Pre-PASC consultation -
  • Pre-MSAC consultation -
  • Outcome Supported

Application details

Reason for application

-

Service or technology in this application

Three tests used in the diagnosis and management of tuberculosis:

  • Nucleic acid Amplification Test (NAAT) for diagnosis of tuberculosis (TB) infection in a person with clinical signs and symptoms of TB
  • NAAT for Mycobacterial infection other than tuberculosis in tissue biopsy with consistent histopathology
  • Quantiferon Gold or other interferon-gamma release immunoassays (IGRAs), as a substitute for Mantoux test (Tuberculin Skin Test, TST), for use in the diagnosis of latent tuberculosis

Medical condition this application addresses

-

Application documents

Assessment report

Public summary document

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Meetings to consider this application

  • PASC meeting: -
  • ESC meeting: 9 February 2012
  • MSAC meeting: 29 March 2012